Back to Resource Center

Drug-releasing vaginal rings for HIV/STI and pregnancy prevention: a review of recent advances and clinical applications

Adolescent girls and young women (AGYW), as well as pre- and post-menopausal women globally would benefit from expanded choice to address their sexual and reproductive health (SRH) needs related to Human Immunodeficiency Virus (HIV), sexually transmitted infections (STIs) and pregnancy prevention. Lack of adequate preventative vaccines for HIV/STIs reinforces public health prioritization for options women may use to mitigate risk for infectious disease and unplanned pregnancy. Drug releasing intravaginal rings (IVRs) represent one such technology that has garnered attention based on the modality’s success as a pre-exposure prophylaxis (PrEP) delivery option in HIV risk reduction.

January 2022

Click for full info +

Full Info:


Resource Type:

Database
Journal Article
Journal Article
MPT Articles
MPT Article
Resource

Citation:

Adolescent girls and young women (AGYW), as well as pre- and post-menopausal women globally would benefit from expanded choice to address their sexual and reproductive health (SRH) needs related to Human Immunodeficiency Virus (HIV), sexually transmitted infections (STIs) and pregnancy prevention. Lack of adequate preventative vaccines for HIV/STIs reinforces public health prioritization for options women may use to mitigate risk for infectious disease and unplanned pregnancy. Drug releasing intravaginal rings (IVRs) represent one such technology that has garnered attention based on the modality’s success as a pre-exposure prophylaxis (PrEP) delivery option in HIV risk reduction.

View Journal Article

Authors: Palanee-Phillips, T ; Baum, MM ; Moss, JA ; Clark, MR ; Nuttall, J ; and Romano, JW

Health Risks(s):

  • HIV
  • STI / STD

Product type(s):

  • IVR

Topic(s):

  • MPTs

Back to Resource Center